Description

Geftinat 250 mg Tablet – Targeted Therapy for Non-Small Cell Lung Cancer (NSCLC)

Geftinat 250 mg is an advanced prescription medication used in the treatment of non-small cell lung cancer (NSCLC). It contains Gefitinib, a type of drug known as an EGFR inhibitor (epidermal growth factor receptor inhibitor). Geftinat 250 is most commonly prescribed for patients whose cancer has spread to other parts of the body and whose tumors carry specific mutations in the EGFR gene.

This medicine belongs to a class of targeted cancer therapies and is a preferred option for patients who test positive for EGFR mutations, making the treatment more precise, effective, and personalized.

What is Geftinat 250?

Geftinat 250 mg is a formulation of Gefitinib 250 mg, a drug that interferes with cancer cell growth and multiplication. It is specifically indicated for patients with locally advanced or metastatic NSCLC, particularly when the tumor cells show EGFR gene mutations. By targeting the overactive EGFR pathway, This medicine helps to block tumor growth and slow disease progression.

This drug is manufactured to meet international pharmaceutical quality standards and is commonly used in oncology clinics and cancer care centers worldwide.

Key Uses of Geftinat 250

This medicine is mainly used for:

• First-line treatment of NSCLC in patients with EGFR mutation-positive tumors

• Maintenance therapy in patients who have responded to previous cancer treatment

• Second-line therapy if cancer returns or progresses after chemotherapy

• Palliative care in metastatic NSCLC cases to prolong survival and relieve symptoms

It is important to undergo EGFR mutation testing before starting treatment with this medicine, as the drug is effective only in mutation-positive cases.

How Geftinat 250 Works

Gefitinib, the active ingredient in this medicine, works by blocking the activity of EGFR, a protein found on the surface of many cancer cells. In patients with EGFR gene mutations, this receptor becomes overactive, leading to uncontrolled cancer cell growth.

By targeting and blocking this receptor, this medicine stops the cancer cells from growing and spreading, leading to tumor shrinkage and delayed progression of the disease.

Benefits of Geftinat 250

• Targeted cancer treatment with fewer side effects than chemotherapy

• Specifically effective in EGFR-mutated NSCLC

• Oral tablet form – no need for hospital visits for injections

• Can reduce tumor size and improve lung function

• Slows cancer progression and extends survival time

• Often better tolerated than traditional chemotherapy

Dosage and Administration

• Standard dose: One Geftinat 250 mg tablet taken once daily

• It can be taken with or without food

• Swallow the tablet whole with water

• Do not crush, chew, or split the tablet

• Always follow your oncologist’s exact dosage instructions

Regular monitoring of liver function, kidney function, and lung health is required during treatment. Your doctor may also order routine imaging scans to track tumor response.

Side Effects of Geftinat 250

Like all cancer medications, Geftinat 250 may cause side effects. However, being a targeted therapy, it often causes fewer severe side effects compared to chemotherapy.

Common Side Effects:

• Diarrhea

• Skin rash or dryness

• Nausea and vomiting

• Loss of appetite

• Weakness or fatigue

• Mouth ulcers

Serious Side Effects (Seek Immediate Medical Help):

• Breathing difficulty (may indicate interstitial lung disease)

• Severe diarrhea or dehydration

• Liver damage (yellowing of skin or eyes)

• Eye irritation or changes in vision

• Allergic reaction (rash, itching, swelling)

Report any unusual or worsening symptoms to your doctor immediately.

Who Should NOT Take Geftinat 250?

Avoid Geftinat 250 if you:

• Are allergic to Gefitinib or any of the tablet ingredients

• Have severe liver or kidney disease

• Are pregnant or planning pregnancy

• Are breastfeeding

• Have severe lung conditions (discuss with your doctor)

Use in Pregnancy and Breastfeeding

Geftinat 250 is not safe during pregnancy as it may harm the unborn baby. Effective contraception must be used during treatment and for a few months after stopping the medication.

Similarly, breastfeeding is not recommended while taking this medication due to the risk of serious side effects in infants.

Buy Geftinat 250 Online – Fast Delivery & Genuine Product

If you are undergoing treatment for NSCLC, you can now order Geftinat 250 online from certified pharmacy platforms. Ensure that you are purchasing from authorized sellers to receive authentic, high-quality medication.

Why Order Geftinat 250 Online From Us?

• Affordable and competitive pricing

• 100% genuine medication

• Cold chain compliant packaging (where applicable)

• Fast, secure, and discreet doorstep delivery

• Simple prescription upload process

• Reliable customer support

Place your order now and receive Geftinat 250 at your doorstep without delays.

Storage Instructions

• Store in a cool, dry place below 30°C

• Keep the medication in its original packaging

• Do not use expired tablets

• Keep out of reach of children and pets

Frequently Asked Questions (FAQs)

Q1. Is this medicine chemotherapy?
A1. No, this medicine is not traditional chemotherapy. It is a targeted therapy that blocks EGFR signals in cancer cells.

Q2. How long do I need to take this medicine?
A2. Treatment duration varies by patient. Your oncologist will determine this based on your response and disease progression.

Q3. Can this medicine cure lung cancer?
A3. This medicine helps control and slow down cancer, but it is not a guaranteed cure. It improves survival and quality of life.

Q4. What tests are required before starting this medicine?
A4. An EGFR mutation test is necessary before starting this treatment to ensure it’s the right drug for your type of lung cancer.

Q5. Can I take other medications with this medicine?
A5. Always inform your doctor about all the medications you are taking. Some drugs may interfere with the effectiveness of this medicine.

Final Thoughts

Geftinat 250 mg tablet is a proven and effective treatment for EGFR mutation-positive non-small cell lung cancer, offering hope to patients who previously had limited options. Its targeted approach makes it less toxic than chemotherapy, while still providing meaningful results in tumor control and symptom management.

For patients and families battling advanced lung cancer, Geftinat 250 offers a modern, research-backed, and accessible treatment option that can be ordered online with convenience, safety, and confidence.